» Authors » Marc J Kaufman

Marc J Kaufman

Explore the profile of Marc J Kaufman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 61
Citations 1276
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaufman M, Meloni E
Med Gas Res . 2025 Jan; 15(2):234-253. PMID: 39812023
Xenon gas is considered to be a safe anesthetic and imaging agent. Research on its other potentially beneficial effects suggests that xenon may have broad efficacy for treating health disorders....
2.
Kaufman M, Hudson J, Kanayama G, Muse S, Schnabel J, Sokoll R, et al.
Am J Drug Alcohol Abuse . 2024 Oct; 50(5):670-681. PMID: 39373343
Long-term use of supraphysiologic doses of anabolic-androgenic steroids (AAS) has been associated with impaired visuospatial memory in young men but little is known about its cognitive effects in middle-aged men....
3.
Sangchooli A, Zare-Bidoky M, Fathi Jouzdani A, Schacht J, Bjork J, Claus E, et al.
JAMA Psychiatry . 2024 Feb; 81(4):414-425. PMID: 38324323
Importance: In the last 25 years, functional magnetic resonance imaging drug cue reactivity (FDCR) studies have characterized some core aspects in the neurobiology of drug addiction. However, no FDCR-derived biomarkers...
4.
Hudson J, Hudson Y, Kanyama G, Schnabel J, Javaras K, Kaufman M, et al.
Drug Alcohol Depend Rep . 2024 Feb; 10:100215. PMID: 38304122
Background: Prior research has demonstrated associations between anabolic-androgenic steroid (AAS) use and features from several childhood and adolescent psychosocial domains including body image concerns, antisocial traits, and low levels of...
5.
Kaufman M, Meloni E, Qrareya A, Paronis C, Bogin V
Drug Alcohol Depend . 2023 Dec; 255:110967. PMID: 38150894
Background: Opioid withdrawal symptoms (OWS) are highly aversive and prompt unprescribed opioid use, which increases morbidity, mortality, and, among individuals being treated for opioid use disorder (OUD), recurrence. OWS are...
6.
Qrareya A, Mahdi F, Kaufman M, Ashpole N, Paris J
Aging (Albany NY) . 2022 Jul; 14(13):5345-5365. PMID: 35830469
In the U.S. about half of the HIV-infected individuals are aged 50 and older. In men living with HIV, secondary hypogonadism is common and occurs earlier than in seronegative men,...
7.
Kaufman M, Qrareya A, Paris J
Aging (Albany NY) . 2022 May; 14(11):4618-4619. PMID: 35622387
No abstract available.
8.
Vitaliano G, Kim J, Kaufman M, Adam C, Zeballos G, Shanmugavadivu A, et al.
Commun Biol . 2022 Mar; 5(1):236. PMID: 35301411
Brain derived neurotrophic factor (BDNF) promotes the growth, differentiation, maintenance and survival of neurons. These attributes make BDNF a potentially powerful therapeutic agent. However, its charge, instability in blood, and...
9.
Ekhtiari H, Zare-Bidoky M, Sangchooli A, Janes A, Kaufman M, Oliver J, et al.
Nat Protoc . 2022 Feb; 17(3):567-595. PMID: 35121856
Cue reactivity is one of the most frequently used paradigms in functional magnetic resonance imaging (fMRI) studies of substance use disorders (SUDs). Although there have been promising results elucidating the...
10.
Pope Jr H, Kanayama G, Hudson J, Kaufman M
Am J Addict . 2021 Apr; 30(5):423-432. PMID: 33870584
Background And Objectives: Anabolic-androgenic steroid (AAS) use has become a major worldwide substance use disorder, affecting tens of millions of individuals. Importantly, it is now increasingly recognized that some individuals...